目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 30)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 35)
2.1 RESEARCH DATA
FIGURE 1 ABLATION TECHNOLOGY MARKET: RESEARCH DESIGN METHODOLOGY
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
FIGURE 3 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2 MARKET SIZE ESTIMATION
2.2.1 TOTAL MARKET SIZE: ABLATION TECHNOLOGY MARKET
2.2.1.1 Bottom-up approach
FIGURE 5 MARKET SIZE ESTIMATION: ABLATION TECHNOLOGY MARKET (BOTTOM-UP APPROACH)
2.2.1.2 Growth forecast
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.2.2 MARKET SEGMENT ASSESSMENT (BY PRODUCT, APPLICATION, AND END USER)
FIGURE 7 TOP-DOWN APPROACH
2.2.3 GEOGRAPHIC MARKET ASSESSMENT (BY REGION & COUNTRY)
2.2.4 PRIMARY RESEARCH VALIDATION
2.3 COVID-19 HEALTH ASSESSMENT
2.4 COVID-19 ECONOMIC ASSESSMENT
2.5 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
2.6 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE ABLATION TECHNOLOGY MARKET
2.7 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 ABLATION TECHNOLOGY MARKET: DATA TRIANGULATION METHODOLOGY
2.8 RESEARCH ASSUMPTIONS AND LIMITATIONS
2.8.1 ASSUMPTIONS FOR THE STUDY
2.9 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: ABLATION TECHNOLOGY MARKET

3 EXECUTIVE SUMMARY (Page No. - 50)
FIGURE 11 ABLATION TECHNOLOGY MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 12 ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 13 ABLATION TECHNOLOGY MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 14 ABLATION TECHNOLOGY MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 53)
4.1 ABLATION TECHNOLOGY MARKET OVERVIEW
FIGURE 15 EXPANSION OF THE TARGET POPULATION TO DRIVE MARKET GROWTH
4.2 ABLATION TECHNOLOGY MARKET, BY PRODUCT
FIGURE 16 RADIOFREQUENCY ABLATORS WILL CONTINUE TO DOMINATE THE ABLATION TECHNOLOGY MARKET BY 2026
4.3 ABLATION TECHNOLOGY MARKET, BY END USER
FIGURE 17 HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS ARE THE LARGEST END USERS OF ABLATION TECHNOLOGY

5 MARKET OVERVIEW (Page No. - 55)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing demand for minimally invasive/non-invasive procedures
5.2.1.2 The emergence of next-generation ablation products & technologies
5.2.1.3 Expansion of the target patient population
5.2.1.3.1 Rapid growth in the aging population with a higher risk of targeted diseases
TABLE 3 GERIATRIC POPULATION, BY REGION, 2015 VS 2030
5.2.1.3.2 Growing incidence of sports injuries and cancer
5.2.1.3.3 Growing prevalence of atrial fibrillation and other cardiac conditions
5.2.1.4 The increasing number of hospitals and surgical & ablation centers
5.2.2 RESTRAINTS
5.2.2.1 Insufficient evidence and unfavorable regulatory scenario
5.2.2.2 Strong market positioning of alternative therapies
TABLE 5 ALTERNATIVE THERAPIES/PROCEDURES TO ABLATION
5.2.3 OPPORTUNITIES
5.2.3.1 Growth potential in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Product recalls
5.2.4.2 Reuse and reprocessing of devices
5.2.4.3 Therapeutic challenges and hazardous effects of ablation
5.3 REGULATORY LANDSCAPE
TABLE 6 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING ABLATION DEVICES
5.3.1 NORTH AMERICA
5.3.1.1 US
TABLE 7 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 19 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES
5.3.1.2 Canada
FIGURE 20 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.3.2 EUROPE
FIGURE 21 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES
5.3.3 ASIA PACIFIC
5.3.3.1 Japan
TABLE 10 JAPAN: PMDA CLASSIFICATION OF ABLATION DEVICES
TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)
5.3.3.2 China
TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.3.3.3 India
TABLE 13 INDIA: CDSCO CLASSIFICATION OF ABLATION DEVICES
5.4 VALUE CHAIN ANALYSIS
FIGURE 22 VALUE CHAIN ANALYSIS OF THE ABLATION TECHNOLOGY MARKET
5.5 SUPPLY CHAIN ANALYSIS
TABLE 14 SUPPLY CHAIN ECOSYSTEM
5.6 ECOSYSTEM COVERAGE: PARENT MARKET
5.7 REIMBURSEMENT SCENARIO
TABLE 15 MEDICAL REIMBURSEMENT CPT CODES FOR MICROWAVE AND RADIOFREQUENCY ABLATION PROCEDURES IN THE US (EFFECTIVE JANUARY 1, 2021)
5.8 PRICING TREND ANALYSIS
5.9 TRADE ANALYSIS
5.9.1 TRADE ANALYSIS FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES
TABLE 16 IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY, 2016-2020 (USD BILLION)
5.1 PORTER’S FIVE FORCE ANALYSIS
TABLE 17 ABLATION TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
5.10.1 THREAT FROM NEW ENTRANTS
5.10.2 THREAT OF SUBSTITUTES
5.10.3 BARGAINING POWER OF SUPPLIERS
5.10.4 BARGAINING POWER OF BUYERS
5.10.5 INTENSITY OF COMPETITIVE RIVALRY
5.11 COVID-19 IMPACT ON THE ABLATION TECHNOLOGY MARKET

6 ABLATION TECHNOLOGY MARKET, BY TYPE (Page No. - 83)
6.1 INTRODUCTION
TABLE 18 ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
6.2 RADIOFREQUENCY ABLATION
6.2.1 THE LOW COST OF RADIOFREQUENCY ABLATION CONTRIBUTES TO MARKET GROWTH
TABLE 19 RADIOFREQUENCY ABLATION TECHNOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
6.3 LASER/LIGHT ABLATION
6.3.1 HIGH EFFICACY AND SAFETY DRIVE THE ADOPTION OF LASER/LIGHT ABLATION
TABLE 20 LASER/LIGHT ABLATION TECHNOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
6.4 ULTRASOUND ABLATION
6.4.1 TECHNOLOGICAL ADVANCEMENTS IN THE ULTRASOUND ABLATION SEGMENT WILL BOOST MARKET GROWTH
TABLE 21 ULTRASOUND ABLATION TECHNOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
6.5 ELECTRICAL ABLATION
6.5.1 THE USE OF ELECTRICAL ABLATION TECHNOLOGY IN CARDIOVASCULAR AND CANCER CONDITIONS WILL BOOST MARKET GROWTH
TABLE 22 ELECTRICAL ABLATION TECHNOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
6.6 CRYOABLATION
6.6.1 INCREASING FOCUS ON COSMETIC SURGERY IS A KEY MARKET GROWTH DRIVER
TABLE 23 CRYOABLATION TECHNOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
6.7 MICROWAVE ABLATION
6.7.1 ADVANTAGES OVER RF ABLATION WILL ENSURE DEMAND FOR MICROWAVE ABLATION
TABLE 24 MICROWAVE ABLATION TECHNOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
6.8 HYDROTHERMAL/HYDROMECHANICAL ABLATION
6.8.1 INCREASING USAGE IN GYNECOLOGY WILL HELP IN MARKET GROWTH
TABLE 25 HYDROTHERMAL/HYDROMECHANICAL ABLATION TECHNOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)

7 ABLATION TECHNOLOGY MARKET, BY PRODUCT (Page No. - 92)
7.1 INTRODUCTION
TABLE 26 ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
7.2 RADIOFREQUENCY ABLATORS
TABLE 27 RADIOFREQUENCY ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 28 RADIOFREQUENCY ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.2.1 TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS
7.2.1.1 Clinical advantages of temperature-controlled RF ablators over traditional approaches are driving the market
TABLE 29 TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.2.2 FLUID-COOLED RADIOFREQUENCY ABLATORS
7.2.2.1 Better temperature control as compared to other traditional radiofrequency ablators
TABLE 30 FLUID-COOLED RADIOFREQUENCY ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.2.3 ROBOTIC CATHETER MANIPULATION SYSTEMS
7.2.3.1 The effectiveness of remote catheter manipulators in AF will propel market growth
TABLE 31 ROBOTIC CATHETER MANIPULATION SYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.3 LASER/LIGHT ABLATORS
TABLE 32 LASER/LIGHT ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 33 LASER/LIGHT ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.3.1 EXCIMER LASER ABLATORS
7.3.1.1 Increasing use of excimer laser ablators in ophthalmological applications is a key driver of the market
TABLE 34 EXCIMER LASER ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.3.2 COLD LASER ABLATORS
7.3.2.1 Cold laser ablator treatment releases endorphins to support pain management
TABLE 35 COLD LASER ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.4 ULTRASOUND ABLATORS
TABLE 36 ULTRASOUND ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 37 ULTRASOUND ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.4.1 ULTRASONIC SURGICAL ABLATION SYSTEMS
7.4.1.1 Ultrasonic surgical ablators dominate the ultrasound ablators market
TABLE 38 ULTRASONIC SURGICAL ABLATION SYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.4.2 HIGH-INTENSITY FOCUSED ULTRASOUND ABLATORS
7.4.2.1 Low procedural times and reduced bleeding support product adoption
TABLE 39 HIGH-INTENSITY FOCUSED ULTRASOUND ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.4.3 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY SYSTEMS
7.4.3.1 Growing incidence of obesity and diabetes drive the market growth
TABLE 40 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY SYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.4.4 MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATORS
7.4.4.1 A combination of techniques allows for high efficacy
TABLE 41 MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.5 ELECTRICAL ABLATORS
TABLE 42 ELECTRICAL ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 43 ELECTRICAL ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.5.1 ARGON PLASMA/BEAM COAGULATORS
7.5.1.1 Increasing preference for APC is a key driver of the market
TABLE 44 ARGON PLASMA/BEAM COAGULATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.5.2 IRREVERSIBLE ELECTROPORATION ABLATORS
7.5.2.1 IRE provides selective targeting and better control
TABLE 45 IRREVERSIBLE ELECTROPORATION ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.6 CRYOABLATION DEVICES
TABLE 46 CRYOABLATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 47 CRYOABLATION DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
7.6.1 TISSUE CONTACT PROBES
7.6.1.1 The safety and effectiveness of tissue contact probes have driven their use
TABLE 48 TISSUE CONTACT PROBES MARKET, BY REGION, 2019-2026 (USD MILLION)
7.6.2 TISSUE SPRAY PROBES
7.6.2.1 The ability to treat surgically inoperable tumors is driving the use of spray probes
TABLE 49 TISSUE SPRAY PROBES MARKET, BY REGION, 2019-2026 (USD MILLION)
7.6.3 EPIDERMAL & SUBCUTANEOUS CRYOABLATION DEVICES
7.6.3.1 Anesthetic properties of epidermal & subcutaneous probes are supporting market growth
TABLE 50 EPIDERMAL & SUBCUTANEOUS CRYOABLATION DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
7.7 MICROWAVE ABLATORS
TABLE 51 MICROWAVE ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.7.1 MICROWAVE THERMOTHERAPY DEVICES
7.8 HYDROTHERMAL/HYDROMECHANICAL ABLATORS
TABLE 52 HYDROTHERMAL/HYDROMECHANICAL ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.8.1 ENDOMETRIAL HYDROTHERMAL BALLOON ABLATION DEVICES

8 ABLATION TECHNOLOGY MARKET, BY APPLICATION (Page No. - 111)
8.1 INTRODUCTION
TABLE 53 ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
8.2 CARDIOVASCULAR DISEASE TREATMENT
8.2.1 THE GROWTH OF THE TARGET PATIENT POPULATION WILL CONTINUE TO PROPEL THE DEMAND FOR CARDIAC ABLATION DEVICES
TABLE 54 ABLATION TECHNOLOGY MARKET FOR CARDIOVASCULAR DISEASE TREATMENT, BY REGION, 2019-2026 (USD MILLION)
8.3 CANCER TREATMENT
8.3.1 RISING PREVALENCE OF CANCER TO PROPEL MARKET GROWTH
TABLE 55 COUNTRY-WISE CANCER INCIDENCE PER MILLION POPULATION, 2015-2019
8.3.2 LIVER CANCER
8.3.3 KIDNEY CANCER
8.3.4 PROSTATE CANCER
8.3.5 LUNG CANCER
8.3.6 BONE METASTASIS
8.3.7 BREAST CANCER
TABLE 56 ABLATION TECHNOLOGY MARKET FOR CANCER TREATMENT, BY REGION, 2019-2026 (USD MILLION)
8.4 ORTHOPEDIC TREATMENT
8.4.1 GROWING DISEASE PREVALENCE AND RISING GERIATRIC POPULATION DRIVE DEMAND FOR ABLATION IN ORTHOPEDIC TREATMENT
TABLE 57 ABLATION TECHNOLOGY MARKET FOR ORTHOPEDIC TREATMENT, BY REGION, 2019-2026 (USD MILLION)
8.5 COSMETIC/AESTHETIC SURGERY
8.5.1 COSMETIC/AESTHETIC SURGERY TO SEE HIGH GROWTH IN THE COMING YEARS
TABLE 58 ABLATION TECHNOLOGY MARKET FOR COSMETIC/AESTHETIC SURGERY, BY REGION, 2019-2026 (USD MILLION)
8.6 UROLOGICAL TREATMENT
8.6.1 THE HIGH PREVALENCE OF KIDNEY STONES IS A PROMINENT DRIVER OF MARKET GROWTH
TABLE 59 ABLATION TECHNOLOGY MARKET FOR UROLOGICAL TREATMENT, BY REGION, 2019-2026 (USD MILLION)
8.7 GYNECOLOGICAL TREATMENT
8.7.1 INCREASING PREVALENCE OF GYNECOLOGICAL CONDITIONS AND REPRODUCTIVE HEALTH CONCERNS TO BOOST MARKET GROWTH
TABLE 60 ABLATION TECHNOLOGY MARKET FOR GYNECOLOGICAL TREATMENT, BY REGION, 2019-2026 (USD MILLION)
8.8 PAIN MANAGEMENT
8.8.1 RISING DEMAND OF MIS TO HELP SUSTAIN MARKET GROWTH
TABLE 61 ABLATION TECHNOLOGY MARKET FOR PAIN MANAGEMENT, BY REGION, 2019-2026 (USD MILLION)
8.9 OPHTHALMOLOGICAL TREATMENT
8.9.1 THE RISING PREVALENCE OF VISION DISORDERS AND GROWING POPULATION WILL DRIVE THE MARKET GROWTH
TABLE 62 ABLATION TECHNOLOGY MARKET FOR OPHTHALMOLOGICAL TREATMENT, BY REGION, 2019-2026 (USD MILLION)
8.10 OTHER APPLICATIONS
TABLE 63 ABLATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)

9 ABLATION TECHNOLOGY MARKET, BY END USER (Page No. - 122)
9.1 INTRODUCTION
TABLE 64 ABLATION TECHNOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
9.2 HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS
9.2.1 HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS ARE THE MAJOR END USERS OF THE MARKET
TABLE 65 ABLATION TECHNOLOGY MARKET FOR HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS, BY REGION, 2019-2026 (USD MILLION)
9.3 AMBULATORY SURGICAL CENTERS
9.3.1 PATIENTS ARE INCREASINGLY OPTING FOR AMBULATORY CARE AS A MORE CONVENIENT ALTERNATIVE TO HOSPITAL-BASED OUTPATIENT PROCEDURES
TABLE 66 NUMBER OF MEDICARE-CERTIFIED ASCS IN THE US (2013-2018)
TABLE 67 ABLATION TECHNOLOGY MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019-2026 (USD MILLION)
9.4 MEDICAL SPAS & AESTHETIC CLINICS
9.4.1 MEDICAL SPAS & AESTHETIC CLINICS OFFER ABLATION SERVICES FOR ENHANCING THE BEAUTY AND OVERALL WELLNESS OF THE BODY
TABLE 68 ABLATION TECHNOLOGY MARKET FOR MEDICAL SPAS & AESTHETIC CLINICS, BY REGION, 2019-2026 (USD MILLION)
9.5 OTHER END USERS
TABLE 69 ABLATION TECHNOLOGY MARKET FOR OTHER END USERS, BY REGION, 2019-2026 (USD MILLION)

10 ABLATION TECHNOLOGY MARKET, BY REGION (Page No. - 127)
10.1 INTRODUCTION
TABLE 70 ABLATION TECHNOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 23 NORTH AMERICA: ABLATION TECHNOLOGY MARKET SNAPSHOT
TABLE 71 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 72 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 73 NORTH AMERICA: RADIOFREQUENCY ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 74 NORTH AMERICA: LASER/LIGHT ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 75 NORTH AMERICA: ULTRASOUND ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 76 NORTH AMERICA: ELECTRICAL ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 77 NORTH AMERICA: CRYOABLATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 78 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 79 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.2.1 US
10.2.1.1 The rising prevalence of cancer and CVD will propel market growth
TABLE 80 US: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 The high burden of cancer supports market growth
TABLE 81 CANADA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
10.3 EUROPE
TABLE 82 EUROPE: ABLATION TECHNOLOGY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 83 EUROPE: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 84 EUROPE: RADIOFREQUENCY ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 85 EUROPE: LASER/LIGHT ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 86 EUROPE: ULTRASOUND ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 87 EUROPE: ELECTRICAL ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 88 EUROPE: CRYOABLATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 89 EUROPE: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 90 EUROPE: ABLATION TECHNOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Highly developed healthcare infrastructure and rising disease incidence ensure strong growth prospects
TABLE 91 GERMANY: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 Growing geriatric population to support market growth in France
TABLE 92 FRANCE: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION
10.3.3 UK
10.3.3.1 Rising geriatric population is supporting the market growth in the UK
TABLE 93 UK: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Rising awareness to support market growth
TABLE 94 ITALY: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing government funding for research to support market growth
TABLE 95 SPAIN: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 96 ROE: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 24 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET SNAPSHOT
TABLE 97 APAC: ABLATION TECHNOLOGY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 98 APAC: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 99 APAC: RADIOFREQUENCY ABLATORS MARKET, BY TYPE,2019-2026 (USD MILLION)
TABLE 100 APAC: LASER/LIGHT ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 101 APAC: ULTRASOUND ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 102 APAC: ELECTRICAL ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 103 APAC: CRYOABLATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 104 APAC: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 105 APAC: ABLATION TECHNOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Presence of universal healthcare reimbursement scenario and growing geriatric population—key factors driving market growth
TABLE 106 JAPAN: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Increasing patient pool and government initiatives for healthcare development are fueling the market growth
TABLE 107 CHINA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Ongoing modernization and infrastructure development in India to support the market growth
TABLE 108 INDIA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 Rising research investments and awareness campaigns are the key factors supporting market growth
TABLE 109 AUSTRALIA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
10.4.5 SOUTH KOREA
10.4.5.1 Rising R&D and promising clinical trials in the country to positively impact market growth
TABLE 110 SOUTH KOREA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
10.4.6 REST OF ASIA PACIFIC
TABLE 111 ROAPAC: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
10.5 LATIN AMERICA
TABLE 112 LATAM: ABLATION TECHNOLOGY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 113 LATAM: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 114 LATAM: RADIOFREQUENCY ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 115 LATAM: LASER/LIGHT ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 116 LATAM: ULTRASOUND ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 117 LATAM: ELECTRICAL ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 118 LATAM: CRYOABLATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 119 LATAM: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 120 LATAM: ABLATION TECHNOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Brazil is a key market in Latin America owing to the modernization of healthcare facilities
TABLE 121 BRAZIL: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Availability of advanced care and increasing awareness programs are fueling market growth in Mexico
TABLE 122 MEXICO: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 123 ROE: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN THE MEA
TABLE 124 MEA: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 125 MEA: RADIOFREQUENCY ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 126 MEA: LASER/LIGHT ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 127 MEA: ULTRASOUND ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 128 MEA: ELECTRICAL ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 129 MEA: CRYOABLATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 130 MEA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 131 MEA: ABLATION TECHNOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 167)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY KEY ABLATION TECHNOLOGY PROVIDERS
11.3 REVENUE SHARE ANALYSIS
FIGURE 26 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ABLATION TECHNOLOGY MARKET
11.4 MARKET SHARE ANALYSIS
FIGURE 27 MEDTRONIC HELD THE LEADING POSITION IN THE ABLATION TECHNOLOGY MARKET IN 2020
TABLE 132 ABLATION TECHNOLOGY MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS)
11.5.1 STARS
11.5.2 PERVASIVE PLAYERS
11.5.3 EMERGING LEADERS
11.5.4 PARTICIPANTS
FIGURE 28 ABLATION TECHNOLOGY MARKET: COMPANY EVALUATION QUADRANT, 2020
11.6 COMPANY EVALUATION QUADRANT (SMES/START-UPS)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 29 ABLATION TECHNOLOGY MARKET: COMPANY EVALUATION QUADRANT FOR SMES/START-UPS, 2020
11.7 COMPETITIVE BENCHMARKING
FIGURE 30 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ABLATION TECHNOLOGY MARKET
TABLE 133 COMPANY APPLICATION FOOTPRINT
TABLE 134 COMPANY REGIONAL FOOTPRINT
11.8 COMPETITIVE SCENARIO AND TRENDS
11.8.1 PRODUCT LAUNCHES & APPROVALS
11.8.2 DEALS
11.8.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES (Page No. - 177)
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1 KEY PLAYERS
12.1.1 MEDTRONIC
TABLE 135 MEDTRONIC: BUSINESS OVERVIEW
FIGURE 31 MEDTRONIC: COMPANY SNAPSHOT
TABLE 136 MEDTRONIC: PRODUCT OFFERINGS
12.1.2 JOHNSON & JOHNSON
TABLE 137 JOHNSON & JOHNSON: BUSINESS OVERVIEW
FIGURE 32 JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 138 JOHNSON & JOHNSON: PRODUCT OFFERINGS
12.1.3 ABBOTT LABORATORIES
TABLE 139 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 33 ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 140 ABBOTT LABORATORIES: PRODUCT OFFERINGS
12.1.4 BOSTON SCIENTIFIC CORPORATION
TABLE 141 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 142 BOSTON SCIENTIFIC CORPORATION: PRODUCT OFFERINGS
12.1.5 ANGIODYNAMICS
TABLE 143 ANGIODYNAMICS: BUSINESS OVERVIEW
FIGURE 35 ANGIODYNAMICS: COMPANY SNAPSHOT
TABLE 144 ANGIODYNAMICS: PRODUCT OFFERINGS
12.1.6 ATRICURE
TABLE 145 ATRICURE: BUSINESS OVERVIEW
FIGURE 36 ATRICURE: COMPANY SNAPSHOT
TABLE 146 ATRICURE: PRODUCT OFFERINGS
12.1.7 CONMED CORPORATION
TABLE 147 CONMED: BUSINESS OVERVIEW
FIGURE 37 CONMED CORPORATION: COMPANY SNAPSHOT
TABLE 148 CONMED: PRODUCT OFFERINGS
12.1.8 OLYMPUS CORPORATION
TABLE 149 OLYMPUS CORPORATION: BUSINESS OVERVIEW
FIGURE 38 OLYMPUS CORPORATION: COMPANY SNAPSHOT
TABLE 150 OLYMPUS CORPORATION: PRODUCT OFFERINGS
12.1.9 SMITH & NEPHEW
TABLE 151 SMITH & NEPHEW: BUSINESS OVERVIEW
FIGURE 39 SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 152 SMITH & NEPHEW: PRODUCT OFFERINGS
12.1.10 STRYKER CORPORATION
TABLE 153 STRYKER: BUSINESS OVERVIEW
FIGURE 40 STRYKER CORPORATION: COMPANY SNAPSHOT
TABLE 154 STRYKER: PRODUCT OFFERINGS
12.1.11 DORNIER MEDTECH
TABLE 155 DORNIER MEDTECH: BUSINESS OVERVIEW
TABLE 156 DORNIER MEDTECH: PRODUCT OFFERINGS
12.1.12 CYNOSURE
TABLE 157 CYNOSURE: BUSINESS OVERVIEW
TABLE 158 CYNOSURE: PRODUCT OFFERINGS
12.1.13 VARIAN MEDICAL SYSTEMS
TABLE 159 VARIAN MEDICAL SYSTEMS: BUSINESS OVERVIEW
FIGURE 41 VARIAN MEDICAL SYSTEMS.: COMPANY SNAPSHOT
TABLE 160 VARIAN MEDICAL SYSTEMS: PRODUCT OFFERINGS
12.1.14 INMODE
TABLE 161 INMODE: BUSINESS OVERVIEW
FIGURE 42 INMODE: COMPANY SNAPSHOT
TABLE 162 INMODE: PRODUCT OFFERINGS
12.2 OTHER COMPANIES
12.2.1 EDAP TMS
12.2.2 LUMENIS
12.2.3 ARTHREX
12.2.4 ICECURE
12.2.5 MERIT MEDICAL
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 219)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS